Mangoceuticals Inc MGRX

$0.24 +0.01 (5.35%)

Valuation

Market cap
4,999,000
Revenue TTM
$460,000
Net income TTM
$-20,640,000
PE ratio
0.00
Forward PE
—
Profit margin
-4,486.96%
Debt to equity
0.00

Trading

Volume
323,200
Avg volume
619,166
Day's range
$0.22 – $0.25
Shares out
21,567,000
Stochastic %K
15%
Beta
1.98
Analysts
Strong Buy
Price target
—

Price

Company profile

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testoste...

Show more

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Industry
Health Information Services
Sector
Healthcare
Phone
214 242 9619
Website
https://www.mangoceuticals.com
Address
17130 N. Dallas Parkway, Suite 240, Dallas, United States

Latest news

No headlines yet.